title: Therapeutic criteria in hydrocephalic children.
abstract: The xanthine, hypoxanthine, and total oxypurine levels were determined in the CSF of 28 hydrocephalic patients (age from newborn to 2 years) and 8 healthy controls using HPLC. The Evans' index, the mean weekly increase in cranial circumference, and the intracranial pressure were also measured. Of the hydrocephalic patients 13 were self-compensated and the other 15 had a shunt implanted during the course of the study. The mean xanthine, hypoxanthine, and total oxypurine levels in the normal children were 5.20, 5.94, and 11.29 mumol/l, respectively. In the self-compensated hydrocephalics these levels were 5.17, 5.71, and 10.79 mumol/l, respectively. In the noncompensated hydrocephalics, they were 9.90, 9.91, and 19.82 mumol/l. The differences between the latter group and the first two are statistically significant (P less than 0.001). The mean Evans' index and the mean weakly increase in cranial circumference in the self-compensated hydrocephalics were 0.35 and 0.25 cm, respectively. In the noncompensated hydrocephalics, they were 0.55 and 0.95 cm. The differences between the two groups are statistically significant (P less than 0.001). Two weeks after implantation of shunts in the noncompensated cases, the mean xanthine, hypoxanthine, and total oxypurine levels fell to 4.22, 4.57, and 8.80 mumol/l, respectively. These changes are statistically significant (P less than 0.001). We think that the two criteria (clinical and biochemical) are equally useful for the prediction of self-compensation in hydrocephalic children and that the oxypurine values after shunt implantation can be used to monitor progress in noncompensated cases.
authors.affiliation: Department of Pediatrics, Hospital General de Galicia, School of Medicine, University of Santiago de Compostela, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Castro-Gago
authors.forename: I N
authors.initials: IN
authors.lastname: Rodriguez
authors.forename: A
authors.initials: A
authors.lastname: Rodriguez-Núñez
authors.forename: J P
authors.initials: JP
authors.lastname: Guitián
authors.forename: S L
authors.initials: SL
authors.lastname: Rocamonde
authors.forename: S
authors.initials: S
authors.lastname: Rodriguez-Segade
mesh_terms: D006801:Humans; D006849:Hydrocephalus / Q000134:cerebrospinal fluid / Q000601:surgery*; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000134:cerebrospinal fluid; D007223:Infant; D007231:Infant, Newborn; D011688:Purinones / Q000134:cerebrospinal fluid*; D014527:Uric Acid / Q000134:cerebrospinal fluid; D019820:Xanthine; D014970:Xanthines / Q000134:cerebrospinal fluid
chemical_list: D007042:Hypoxanthines; D011688:Purinones; D014970:Xanthines; D019820:Xanthine; D014527:Uric Acid; D019271:Hypoxanthine